View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Part 3 of an ongoing 12-part COVID-19 series, Sharon Lewin, AO, FRACP, PhD, FAAHMS, provides a brief update on the latest incidence trends and a concise guide to the management of mild and moderate disease. After the update, Dr. Lewin answers critical clinician questions on COVID-19 transmission, diagnosis, and management.
Content based on an online CME program supported by an independent educational grant from Gilead Sciences.
Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Download slides reviewing the latest data and guidance on COVID-19 symptoms and clinical manifestations, from Clinical Care Options (CCO)
Arthur Kim, MD
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Kristen Marks, MD
Renslow Sherer, MD
Released: May 17, 2022
Downloadable slides from CCO on the rationale and evidence supporting timeliness in the administration of therapies that act directly against SARS-CoV-2
Michael G. Ison, MD, MS
Arthur Kim, MD
Lynora Saxinger, MD, FRCPC, CTropMed
Released: May 11, 2022
Download slides reviewing the latest data and guidance on COVID-19 treatments, including authorized and investigational agents, from Clinical Care Options (CCO)
Arthur Kim, MD
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Kristen Marks, MD
Renslow Sherer, MD
Released: May 10, 2022
Expert selections of important COVID-19 data from ECCMID 2022, including treatment, vaccination, and long COVID, from Clinical Care Options (CCO)
Cristina Mussini, MD
Released: May 9, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.